Author

Henry E. Pertinez

University of LiverpoolORCID 0009-0004-4522-9201Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrew OweniD· 2 shared Eric L. NuermbergeriD· 1 shared J. HobsoniD· 1 shared Joanne SharpiD· 1 shared Nader FotouhiiD· 1 shared Nicole C. AmmermaniD· 1 shared Saye Khoo· 1 shared Si-Yang Li· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Andrew OwenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

One-Dose Efficacy of Long-Acting Sorfequiline in a Mouse Model of Tuberculosis Preventive Therapy

Si-Yang Li, J. Hobson, Nicole C. Ammerman, Henry E. Pertinez, Joanne Sharp, Nader Fotouhi, Steve P. Rannard, Andrew Owen, Eric L. Nuermberger

This study evaluates the efficacy of a single dose of long-acting sorfequiline in a mouse model for tuberculosis preventive therapy.

bioRxiv · Sep 24, 2026 · PreprintMicrobiology

Dose optimisation of favipiravir against RNA viruses using physiologically-based pharmacokinetic modelling.

William HJ Wood, Henry E. Pertinez, Tim Rowland, Andrew Owen, Tom Fletcher, Saye Khoo

This study optimizes favipiravir doses against RNA viruses using physiologically-based pharmacokinetic modeling, showing safe dosing ranges and effects of chronic kidney disease.

bioRxiv · Jun 26, 2026 · PreprintPharmacology & Toxicology